Find Federal Grants
COVID-19 Response Supplement: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement.
Centers for Disease Control - OSTLTS · CDC-RFA-OT18-18030202SUPP20
Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-20-024
Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-DC-20-001
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
National Institutes of Health · PA-20-145
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
National Institutes of Health · PA-20-144
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Coordinating Center (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HG-20-002
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HG-20-001
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
National Institutes of Health · RFA-AI-20-007
Protecting and Improving Public Health in Pakistan: Strengthening and Sustaining Public Health Impact, Systems, Capacity, and Security
Centers for Disease Control - CGH · CDC-RFA-GH20-2099
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
National Institutes of Health · PA-20-142
Strengthening environmental health capacity (EHC) to detect, prevent, and control environmental health hazards through data-driven, evidence-based approaches
Centers for Disease Control - NCEH · CDC-RFA-EH20-2005
National Institutes of Health · PAR-20-143
Strengthening sustainable public health capacity in the Eastern Mediterranean Region for polio eradication and routine immunization activities
Centers for Disease Control - CGH · CDC-RFA-GH16-16010501SUPP20
National Institutes of Health · RFA-HD-21-005
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
National Institutes of Health · RFA-HG-20-016
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
National Institutes of Health · RFA-HG-20-014
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
National Institutes of Health · PA-20-141
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed)
National Institutes of Health · RFA-HG-20-015
Bureau of Justice Assistance · BJA-2020-17114
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
Centers for Disease Control - OSTLTS · CDC-RFA-OT18-18020202SUPP20